A Repeat Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Subjects

NCT00896558 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Bacterial

Interventions

DRUG: GSK1322322/placebo
DRUG: GSK1322322/placebo and midazolam

Sponsor

GlaxoSmithKline